Conversely, expression of Smad2, Smad3, alone or together (Fig. 6F) promoted an EMT-like phenotype even in the absence of exogenous TGFβ in breast carcinoma organoids (Fig. 6G-H). Here, SMAD2 is linked to breast carcinoma.